Report cover image

Global Escherichia Coli Testing Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Jan 01, 2026
Length 217 Pages
SKU # APRC20797806

Description

The global Escherichia Coli Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Escherichia Coli Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Escherichia Coli Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for Escherichia Coli Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Escherichia Coli Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Escherichia Coli Testing include Abbott, BD, BioMerieux, Novartis, Olympus Corporation, Lonza Group, Merck, Johnson & Johnson and Danaher Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Escherichia Coli Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Escherichia Coli Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Escherichia Coli Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Escherichia Coli Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Escherichia Coli Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Escherichia Coli Testing revenue, projected growth trends, production technology, application and end-user industry.

Escherichia Coli Testing Segment by Company

Abbott
BD
BioMerieux
Novartis
Olympus Corporation
Lonza Group
Merck
Johnson & Johnson
Danaher Corporation
Thermo Fisher Scientific
GE Healthcare
Fujifilm
Corning
Enzo Life Sciences
Hologic
Idexx Laboratories
Meridian Bioscience
SSI Diagnostica
Bio Rad Laboratories
HiMedia Laboratories
RAKIRO BIOTECH SYSTEMS
Cell Culture Technologies
Caisson Laboratories

Escherichia Coli Testing Segment by Type

Environmental Testing
Clinical Testing

Escherichia Coli Testing Segment by Application

Diagnostic Laboratories and Hospital
Waste Water Treatment Organizations
Water Suppliers
Research Laboratories
Government Agencies
Others

Escherichia Coli Testing Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Escherichia Coli Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Escherichia Coli Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Escherichia Coli Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Escherichia Coli Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Escherichia Coli Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Escherichia Coli Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

217 Pages
1 Market Overview
1.1 Product Definition
1.2 Escherichia Coli Testing Market by Type
1.2.1 Global Escherichia Coli Testing Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 Environmental Testing
1.2.3 Clinical Testing
1.3 Escherichia Coli Testing Market by Application
1.3.1 Global Escherichia Coli Testing Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Diagnostic Laboratories and Hospital
1.3.3 Waste Water Treatment Organizations
1.3.4 Water Suppliers
1.3.5 Research Laboratories
1.3.6 Government Agencies
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Escherichia Coli Testing Market Dynamics
2.1 Escherichia Coli Testing Industry Trends
2.2 Escherichia Coli Testing Industry Drivers
2.3 Escherichia Coli Testing Industry Opportunities and Challenges
2.4 Escherichia Coli Testing Industry Restraints
3 Global Growth Perspective
3.1 Global Escherichia Coli Testing Market Perspective (2021-2032)
3.2 Global Escherichia Coli Testing Growth Trends by Region
3.2.1 Global Escherichia Coli Testing Market Size by Region: 2021 VS 2025 VS 2032
3.2.2 Global Escherichia Coli Testing Market Size by Region (2021-2026)
3.2.3 Global Escherichia Coli Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
4.1 Global Escherichia Coli Testing Revenue by Players
4.1.1 Global Escherichia Coli Testing Revenue by Players (2021-2026)
4.1.2 Global Escherichia Coli Testing Revenue Market Share by Players (2021-2026)
4.1.3 Global Escherichia Coli Testing Players Revenue Share Top 10 and Top 5 in 2025
4.2 Global Escherichia Coli Testing Key Players Ranking, 2024 VS 2025 VS 2026
4.3 Global Escherichia Coli Testing Key Players Headquarters & Area Served
4.4 Global Escherichia Coli Testing Players, Product Type & Application
4.5 Global Escherichia Coli Testing Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Escherichia Coli Testing Market CR5 and HHI
4.6.3 2025 Escherichia Coli Testing Tier 1, Tier 2, and Tier 3
5 Escherichia Coli Testing Market Size by Type
5.1 Global Escherichia Coli Testing Revenue by Type (2021 VS 2025 VS 2032)
5.2 Global Escherichia Coli Testing Revenue by Type (2021-2032)
5.3 Global Escherichia Coli Testing Revenue Market Share by Type (2021-2032)
6 Escherichia Coli Testing Market Size by Application
6.1 Global Escherichia Coli Testing Revenue by Application (2021 VS 2025 VS 2032)
6.2 Global Escherichia Coli Testing Revenue by Application (2021-2032)
6.3 Global Escherichia Coli Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Business Overview
7.1.3 Abbott Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.1.4 Abbott Escherichia Coli Testing Product Portfolio
7.1.5 Abbott Recent Developments
7.2 BD
7.2.1 BD Company Information
7.2.2 BD Business Overview
7.2.3 BD Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.2.4 BD Escherichia Coli Testing Product Portfolio
7.2.5 BD Recent Developments
7.3 BioMerieux
7.3.1 BioMerieux Company Information
7.3.2 BioMerieux Business Overview
7.3.3 BioMerieux Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.3.4 BioMerieux Escherichia Coli Testing Product Portfolio
7.3.5 BioMerieux Recent Developments
7.4 Novartis
7.4.1 Novartis Company Information
7.4.2 Novartis Business Overview
7.4.3 Novartis Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.4.4 Novartis Escherichia Coli Testing Product Portfolio
7.4.5 Novartis Recent Developments
7.5 Olympus Corporation
7.5.1 Olympus Corporation Company Information
7.5.2 Olympus Corporation Business Overview
7.5.3 Olympus Corporation Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.5.4 Olympus Corporation Escherichia Coli Testing Product Portfolio
7.5.5 Olympus Corporation Recent Developments
7.6 Lonza Group
7.6.1 Lonza Group Company Information
7.6.2 Lonza Group Business Overview
7.6.3 Lonza Group Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.6.4 Lonza Group Escherichia Coli Testing Product Portfolio
7.6.5 Lonza Group Recent Developments
7.7 Merck
7.7.1 Merck Company Information
7.7.2 Merck Business Overview
7.7.3 Merck Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.7.4 Merck Escherichia Coli Testing Product Portfolio
7.7.5 Merck Recent Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Information
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.8.4 Johnson & Johnson Escherichia Coli Testing Product Portfolio
7.8.5 Johnson & Johnson Recent Developments
7.9 Danaher Corporation
7.9.1 Danaher Corporation Company Information
7.9.2 Danaher Corporation Business Overview
7.9.3 Danaher Corporation Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.9.4 Danaher Corporation Escherichia Coli Testing Product Portfolio
7.9.5 Danaher Corporation Recent Developments
7.10 Thermo Fisher Scientific
7.10.1 Thermo Fisher Scientific Company Information
7.10.2 Thermo Fisher Scientific Business Overview
7.10.3 Thermo Fisher Scientific Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.10.4 Thermo Fisher Scientific Escherichia Coli Testing Product Portfolio
7.10.5 Thermo Fisher Scientific Recent Developments
7.11 GE Healthcare
7.11.1 GE Healthcare Company Information
7.11.2 GE Healthcare Business Overview
7.11.3 GE Healthcare Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.11.4 GE Healthcare Escherichia Coli Testing Product Portfolio
7.11.5 GE Healthcare Recent Developments
7.12 Fujifilm
7.12.1 Fujifilm Company Information
7.12.2 Fujifilm Business Overview
7.12.3 Fujifilm Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.12.4 Fujifilm Escherichia Coli Testing Product Portfolio
7.12.5 Fujifilm Recent Developments
7.13 Corning
7.13.1 Corning Company Information
7.13.2 Corning Business Overview
7.13.3 Corning Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.13.4 Corning Escherichia Coli Testing Product Portfolio
7.13.5 Corning Recent Developments
7.14 Enzo Life Sciences
7.14.1 Enzo Life Sciences Company Information
7.14.2 Enzo Life Sciences Business Overview
7.14.3 Enzo Life Sciences Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.14.4 Enzo Life Sciences Escherichia Coli Testing Product Portfolio
7.14.5 Enzo Life Sciences Recent Developments
7.15 Hologic
7.15.1 Hologic Company Information
7.15.2 Hologic Business Overview
7.15.3 Hologic Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.15.4 Hologic Escherichia Coli Testing Product Portfolio
7.15.5 Hologic Recent Developments
7.16 Idexx Laboratories
7.16.1 Idexx Laboratories Company Information
7.16.2 Idexx Laboratories Business Overview
7.16.3 Idexx Laboratories Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.16.4 Idexx Laboratories Escherichia Coli Testing Product Portfolio
7.16.5 Idexx Laboratories Recent Developments
7.17 Meridian Bioscience
7.17.1 Meridian Bioscience Company Information
7.17.2 Meridian Bioscience Business Overview
7.17.3 Meridian Bioscience Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.17.4 Meridian Bioscience Escherichia Coli Testing Product Portfolio
7.17.5 Meridian Bioscience Recent Developments
7.18 SSI Diagnostica
7.18.1 SSI Diagnostica Company Information
7.18.2 SSI Diagnostica Business Overview
7.18.3 SSI Diagnostica Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.18.4 SSI Diagnostica Escherichia Coli Testing Product Portfolio
7.18.5 SSI Diagnostica Recent Developments
7.19 Bio Rad Laboratories
7.19.1 Bio Rad Laboratories Company Information
7.19.2 Bio Rad Laboratories Business Overview
7.19.3 Bio Rad Laboratories Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.19.4 Bio Rad Laboratories Escherichia Coli Testing Product Portfolio
7.19.5 Bio Rad Laboratories Recent Developments
7.20 HiMedia Laboratories
7.20.1 HiMedia Laboratories Company Information
7.20.2 HiMedia Laboratories Business Overview
7.20.3 HiMedia Laboratories Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.20.4 HiMedia Laboratories Escherichia Coli Testing Product Portfolio
7.20.5 HiMedia Laboratories Recent Developments
7.21 RAKIRO BIOTECH SYSTEMS
7.21.1 RAKIRO BIOTECH SYSTEMS Company Information
7.21.2 RAKIRO BIOTECH SYSTEMS Business Overview
7.21.3 RAKIRO BIOTECH SYSTEMS Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.21.4 RAKIRO BIOTECH SYSTEMS Escherichia Coli Testing Product Portfolio
7.21.5 RAKIRO BIOTECH SYSTEMS Recent Developments
7.22 Cell Culture Technologies
7.22.1 Cell Culture Technologies Company Information
7.22.2 Cell Culture Technologies Business Overview
7.22.3 Cell Culture Technologies Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.22.4 Cell Culture Technologies Escherichia Coli Testing Product Portfolio
7.22.5 Cell Culture Technologies Recent Developments
7.23 Caisson Laboratories
7.23.1 Caisson Laboratories Company Information
7.23.2 Caisson Laboratories Business Overview
7.23.3 Caisson Laboratories Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
7.23.4 Caisson Laboratories Escherichia Coli Testing Product Portfolio
7.23.5 Caisson Laboratories Recent Developments
8 North America
8.1 North America Escherichia Coli Testing Revenue (2021-2032)
8.2 North America Escherichia Coli Testing Revenue by Type (2021-2032)
8.2.1 North America Escherichia Coli Testing Revenue by Type (2021-2026)
8.2.2 North America Escherichia Coli Testing Revenue by Type (2027-2032)
8.3 North America Escherichia Coli Testing Revenue Share by Type (2021-2032)
8.4 North America Escherichia Coli Testing Revenue by Application (2021-2032)
8.4.1 North America Escherichia Coli Testing Revenue by Application (2021-2026)
8.4.2 North America Escherichia Coli Testing Revenue by Application (2027-2032)
8.5 North America Escherichia Coli Testing Revenue Share by Application (2021-2032)
8.6 North America Escherichia Coli Testing Revenue by Country
8.6.1 North America Escherichia Coli Testing Revenue by Country (2021 VS 2025 VS 2032)
8.6.2 North America Escherichia Coli Testing Revenue by Country (2021-2026)
8.6.3 North America Escherichia Coli Testing Revenue by Country (2027-2032)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Escherichia Coli Testing Revenue (2021-2032)
9.2 Europe Escherichia Coli Testing Revenue by Type (2021-2032)
9.2.1 Europe Escherichia Coli Testing Revenue by Type (2021-2026)
9.2.2 Europe Escherichia Coli Testing Revenue by Type (2027-2032)
9.3 Europe Escherichia Coli Testing Revenue Share by Type (2021-2032)
9.4 Europe Escherichia Coli Testing Revenue by Application (2021-2032)
9.4.1 Europe Escherichia Coli Testing Revenue by Application (2021-2026)
9.4.2 Europe Escherichia Coli Testing Revenue by Application (2027-2032)
9.5 Europe Escherichia Coli Testing Revenue Share by Application (2021-2032)
9.6 Europe Escherichia Coli Testing Revenue by Country
9.6.1 Europe Escherichia Coli Testing Revenue by Country (2021 VS 2025 VS 2032)
9.6.2 Europe Escherichia Coli Testing Revenue by Country (2021-2026)
9.6.3 Europe Escherichia Coli Testing Revenue by Country (2027-2032)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Escherichia Coli Testing Revenue (2021-2032)
10.2 China Escherichia Coli Testing Revenue by Type (2021-2032)
10.2.1 China Escherichia Coli Testing Revenue by Type (2021-2026)
10.2.2 China Escherichia Coli Testing Revenue by Type (2027-2032)
10.3 China Escherichia Coli Testing Revenue Share by Type (2021-2032)
10.4 China Escherichia Coli Testing Revenue by Application (2021-2032)
10.4.1 China Escherichia Coli Testing Revenue by Application (2021-2026)
10.4.2 China Escherichia Coli Testing Revenue by Application (2027-2032)
10.5 China Escherichia Coli Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia Escherichia Coli Testing Revenue (2021-2032)
11.2 Asia Escherichia Coli Testing Revenue by Type (2021-2032)
11.2.1 Asia Escherichia Coli Testing Revenue by Type (2021-2026)
11.2.2 Asia Escherichia Coli Testing Revenue by Type (2027-2032)
11.3 Asia Escherichia Coli Testing Revenue Share by Type (2021-2032)
11.4 Asia Escherichia Coli Testing Revenue by Application (2021-2032)
11.4.1 Asia Escherichia Coli Testing Revenue by Application (2021-2026)
11.4.2 Asia Escherichia Coli Testing Revenue by Application (2027-2032)
11.5 Asia Escherichia Coli Testing Revenue Share by Application (2021-2032)
11.6 Asia Escherichia Coli Testing Revenue by Country
11.6.1 Asia Escherichia Coli Testing Revenue by Country (2021 VS 2025 VS 2032)
11.6.2 Asia Escherichia Coli Testing Revenue by Country (2021-2026)
11.6.3 Asia Escherichia Coli Testing Revenue by Country (2027-2032)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Escherichia Coli Testing Revenue (2021-2032)
12.2 SAMEA Escherichia Coli Testing Revenue by Type (2021-2032)
12.2.1 SAMEA Escherichia Coli Testing Revenue by Type (2021-2026)
12.2.2 SAMEA Escherichia Coli Testing Revenue by Type (2027-2032)
12.3 SAMEA Escherichia Coli Testing Revenue Share by Type (2021-2032)
12.4 SAMEA Escherichia Coli Testing Revenue by Application (2021-2032)
12.4.1 SAMEA Escherichia Coli Testing Revenue by Application (2021-2026)
12.4.2 SAMEA Escherichia Coli Testing Revenue by Application (2027-2032)
12.5 SAMEA Escherichia Coli Testing Revenue Share by Application (2021-2032)
12.6 SAMEA Escherichia Coli Testing Revenue by Country
12.6.1 SAMEA Escherichia Coli Testing Revenue by Country (2021 VS 2025 VS 2032)
12.6.2 SAMEA Escherichia Coli Testing Revenue by Country (2021-2026)
12.6.3 SAMEA Escherichia Coli Testing Revenue by Country (2027-2032)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.